TOP2A and skin squamous cell carcinoma: While we found TOP2a to be highly expressed in almost all cases of CSCC, in a trial of CSCC patients, orally administered etoposide as a second‐line therapy was only effective in 11% of patients 47, indicating that TOP2a expression status alone may not be predictive of response to topoisomerase II poisons.